RTP drug developer adds $30M to extend cash runway


A drug developer in Research Triangle Park has extended its cash runway as it moves multiple clinical programs forward.

Previous CPA firm with specialized focus now calls downtown Wichita home
Next St. Pete's Catalina files Chapter 11 second time in five years, restructures $370M debt load